Olivia Ross is Senior Director, Clinical Partnerships & Strategy at Transcarent. She specializes in clinical quality assessment, bundled and episode-based payment design, project management ...

Orchestra BioMed’s hypertension treatment is the latest medical device to earn the FDA’s breakthrough designation. Medtronic has a commercialization deal with the company for the device, which ...

Patient expectations continue to evolve, and healthcare practices that fail to adapt risk more than just revenue—they risk losing trust.

Elizabeth Wallner, diagnosed with Stage 4 colon cancer five years ago, has one word to describe the pharmaceutical executive who decided to double the price of Seconal: “Scumbag.” ...

The Rockefeller Foundation is funding two produce prescription pilot programs at VA healthcare systems in Salt Lake City, Utah, and Houston, Texas. Eligible veterans will be able to enroll in ...

Frank Vinluan is senior biopharma reporter for MedCity News. He previously held business reporting positions at Xconomy, The Seattle Times, The Des Moines Register, and the Triangle Business Journal.

Orchestra BioMed’s hypertension treatment is the latest medical device to earn the FDA’s breakthrough designation. The device is an atrio-ventricular interval modulation therapy, meaning it ...

Caribou Biosciences’ 2025 outlook aimed for key trial readouts for two cancer cell therapies in the first half of the year and the start of clinical testing in an autoimmune disease. The CRISPR ...

In 2010, the Affordable Care Act redefined access to healthcare. Fifteen years later, we find ourselves facing a different kind of challenge — not who can enter the system, but how the system ...

Health insurance is rapidly evolving, requiring providers and employers to be adaptable. If you have employees, you must consider what they need from their coverage while considering costs.

Substance use disorder (SUD) remains a costly and dangerous public health challenge that affects over 48 million people in the US annually. High relapse rates, typically 40-60%, lead me to believe ...

The average cost of a healthcare data breach is now $10.93 million, up from $10.10 million in 2022, according to a new report. Healthcare has the highest data breach costs of all industries ...